Universal-Beteiligungs- und Servicegesellschaft’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.74M Buy
48,609
+7,522
+18% +$657K 0.01% 952
2026
Q1
$3.45M Buy
41,087
+30,287
+280% +$1.75M 0.01% 1039
2025
Q4
$445K Sell
10,800
-4,934
-31% -$191K ﹤0.01% 1750
2025
Q3
$619K Buy
+15,734
New +$402K ﹤0.01% 1701

Other funds holding DNTH

Universal-Beteiligungs- und Servicegesellschaft's DNTH Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Dianthus Therapeutics (DNTH) stake by 18% in Q2 2026, buying an estimated $657K and bringing the position to 48,609 shares worth $4.74M. The position accounts for 0.01% of the portfolio, ranked #952.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in DNTH in Q3 2025 and has held it in 4 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 48,609 shares of Dianthus Therapeutics worth $4.74M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 7,522 Dianthus Therapeutics shares in Q2 2026, an estimated $657K.
  • Dianthus Therapeutics made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #952 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Dianthus Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.